| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +0.00% | -6.09% | -0.09% | -5.99% | -5.99% | — |
| 14d | 1 | +0.00% | -3.48% | -0.22% | -3.26% | -3.26% | — |
| 30d | 1 | +100.00% | +21.74% | +3.97% | +17.77% | +17.77% | — |
| 60d | 1 | +0.00% | -5.22% | +7.66% | -12.88% | -12.88% | — |
| 90d | 1 | +0.00% | -40.23% | +3.35% | -43.59% | -43.59% | — |
| 180d | 1 | +0.00% | -52.92% | +14.50% | -67.42% | -67.42% | — |
| 1y | 1 | +0.00% | -70.52% | +24.32% | -94.84% | -94.84% | — |
| 2y | 1 | +0.00% | -89.56% | +62.24% | -151.81% | -151.81% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| LGVN LONGEVERON INC. | PURCHASEGRANT Stock grant | 500,000 | — | — | 789,727 | May 1, 2026 | May 5, 2026 ↗ | View → |
| LGVN LONGEVERON INC. | SALE Chief Executive Officer | 4,740 | $1.12 | $5.3K | 289,727 | Apr 1, 2026 | Apr 3, 2026 ↗ | View → |
| LGVN LONGEVERON INC. | PURCHASEGRANT Stock grant | 200,000 | — | — | 200,000 | Mar 2, 2026 | Mar 13, 2026 ↗ | View → |
| LGVN LONGEVERON INC. | SALE Chief Executive Officer | 105,533 | $0.55 | $57.5K | 94,467 | Mar 2, 2026 | Mar 13, 2026 ↗ | View → |
| LGVN LONGEVERON INC. | PURCHASEGRANT Stock grant | 200,000 | — | — | 294,467 | Mar 2, 2026 | Mar 13, 2026 ↗ | View → |
| LGVN LONGEVERON INC. | PURCHASEGRANT Stock grant | 200,000 | — | — | 200,000 | Mar 2, 2026 | Mar 13, 2026 ↗ | View → |
| NRXP NRX PHARMACEUTICALS, INC. | PURCHASE CHIEF EXECUTIVE OFFICER | 50,000 | $1.17 | $58.5K | 50,000 | Dec 16, 2022 | Dec 18, 2022 ↗ | View → |